Colorado PDAB Says Cosentyx Is Unaffordable

By Luke Zarzecki / June 14, 2024 at 6:30 PM

Colorado’s Prescription Drug Affordability Board voted that Novartis’ Cosentyx is unaffordable for residents of the state Friday (June 14). Cosentyx, used for various forms of psoriasis, arthritis, spondylitis and Hidradenitis Suppurative, is the third drug the board has deemed unaffordable.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.